Mobilaser Study to Help With People Who Are Having Problems With Their Gait
Increasing Mobility in Parkinsonian Patients With Freezing of Gait and Gait Hypokinesia With an Adjustable, Attachable Laser (Mobilaser)
1 other identifier
interventional
11
1 country
1
Brief Summary
Does use of the Mobilaser reduce freezing of gait (FOG) and stride reduction in patients with Parkinson's disease and Parkinsonism.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for early_phase_1
Started May 2012
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 10, 2011
CompletedFirst Posted
Study publicly available on registry
April 20, 2012
CompletedStudy Start
First participant enrolled
May 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2013
CompletedDecember 31, 2015
April 1, 2015
1.6 years
November 10, 2011
December 30, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Improvement in Gait
6 weeks
Study Arms (1)
Mobilaser
EXPERIMENTALPatients will begin by collecting data at home without using the mobilaser. They will then be given the mobilaser to use at home for 6 weeks while they collect data on whether their gait has improved. They will then have to return the Mobilaser to the clinic and collect data at home for 3 days to see if there is a difference.
Interventions
Patients will begin by collecting data at home without using the mobilaser. They will then be given the mobilaser to use at home for 6 weeks while they collect data on whether their gait has improved. They will then have to return the Mobilaser to the clinic and collect data at home for 3 days to see if there is a difference.
Eligibility Criteria
You may qualify if:
- Parkinsonian patients with Freezing of Gait or Gait hesitation.
- Must have evidence of bradykinesia ambulating (stride reduction or reduced arm swing)
- Must have a constant caregiver
You may not qualify if:
- No cardiopulmonary contraindications to ambulation, e.g., unstable angina pectoris;
- Severe arthritis;
- Cerebellar or sensory ataxia;
- Recent knee or hip surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mayo Cliniclead
Study Sites (1)
Mayo Clinic in Florida
Jacksonville, Florida, 32224, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jay Van Gerpen, MD
Mayo Clinic
Study Design
- Study Type
- interventional
- Phase
- early phase 1
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Neurology
Study Record Dates
First Submitted
November 10, 2011
First Posted
April 20, 2012
Study Start
May 1, 2012
Primary Completion
December 1, 2013
Study Completion
December 1, 2013
Last Updated
December 31, 2015
Record last verified: 2015-04